These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29114967)

  • 1. Effect of intravenous immunoglobulin administration on erythrocyte and leucocyte parameters.
    Cicha A; Fischer MB; Wesinger A; Haas S; Bauer WM; Wolf HM; Sauerwein KMT; Reininger B; Petzelbauer P; Pehamberger H; Handisurya A
    J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):1004-1010. PubMed ID: 29114967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
    Ririe MR; Blaylock RC; Morris SE; Jung JY
    J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemolytic anemia associated with intravenous immunoglobulin.
    Wilson JR; Bhoopalam H; Fisher M
    Muscle Nerve; 1997 Sep; 20(9):1142-5. PubMed ID: 9270670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose intravenous immunoglobulins in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese patients: a retrospective study of 82 cases.
    Chen J; Wang B; Zeng Y; Xu H
    Eur J Dermatol; 2010; 20(6):743-7. PubMed ID: 20952352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
    Yang Y; Xu J; Li F; Zhu X
    Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of high-dose intravenous immunoglobulin in systemic autoimmune diseases.
    Tufan F; Kamali S; Erer B; Gul A; Inanc M; Ocal L; Konice M; Aral O
    Clin Rheumatol; 2007 Nov; 26(11):1913-5. PubMed ID: 17636363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel mechanism for therapeutic action of IVIg in autoimmune blistering dermatoses.
    Michael D; Grando SA
    Curr Dir Autoimmun; 2008; 10():333-43. PubMed ID: 18460894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stevens-Johnson syndrome and toxic epidermal necrolysis: efficacy of intravenous immunoglobulin and a review of treatment options.
    Teo L; Tay YK; Liu TT; Kwok C
    Singapore Med J; 2009 Jan; 50(1):29-33. PubMed ID: 19224081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of additional i.v. immunoglobulin to steroid therapy in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Aihara M; Kano Y; Fujita H; Kambara T; Matsukura S; Katayama I; Azukizawa H; Miyachi Y; Endo Y; Asada H; Miyagawa F; Morita E; Kaneko S; Abe R; Ochiai T; Sueki H; Watanabe H; Nagao K; Aoyama Y; Sayama K; Hashimoto K; Shiohara T;
    J Dermatol; 2015 Aug; 42(8):768-77. PubMed ID: 25982480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS): experience with high-dose intravenous immunoglobulins and topical conservative approach. A retrospective analysis.
    Stella M; Clemente A; Bollero D; Risso D; Dalmasso P
    Burns; 2007 Jun; 33(4):452-9. PubMed ID: 17475410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of intravenous immunoglobulin in toxic epidermal necrolysis: a retrospective analysis of 64 patients managed in a specialized centre.
    Lee HY; Lim YL; Thirumoorthy T; Pang SM
    Br J Dermatol; 2013 Dec; 169(6):1304-9. PubMed ID: 24007192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin: an emerging treatment for immune-mediated skin diseases.
    Rütter A; Luger TA
    Curr Opin Investig Drugs; 2002 May; 3(5):713-9. PubMed ID: 12090544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute hemolysis after high-dose intravenous immunoglobulin therapy in highly HLA sensitized patients.
    Kahwaji J; Barker E; Pepkowitz S; Klapper E; Villicana R; Peng A; Chang R; Jordan SC; Vo AA
    Clin J Am Soc Nephrol; 2009 Dec; 4(12):1993-7. PubMed ID: 19833910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Whole-Blood Exchange Transfusion in Refractory Severe Autoimmune Haemolytic Anaemia Secondary to Systemic Lupus Erythematosus: A Real-World Observational Retrospective Study.
    Jiang Y; Zhao HJ; Luo H; Li BJ; Zhang ZM; Zhao LD; Zuo XX
    Front Immunol; 2022; 13():861719. PubMed ID: 35757744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders.
    Gürcan HM; Ahmed AR
    Ann Pharmacother; 2007 May; 41(5):812-23. PubMed ID: 17440006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute hemolysis secondary to high-dose intravenous immunoglobulin in a patient with Stevens-Johnson syndrome.
    Shakouri AA; Bahna SL
    Ann Allergy Asthma Immunol; 2012 Jun; 108(6):463-4. PubMed ID: 22626604
    [No Abstract]   [Full Text] [Related]  

  • 17. European Guidelines (S1) on the use of high-dose intravenous immunoglobulin in dermatology.
    Enk A; Hadaschik E; Eming R; Fierlbeck G; French L; Girolomoni G; Hertl M; Jolles S; Karpati S; Steinbrink K; Stingl G; Volc-Platzer B; Zillikens D
    J Dtsch Dermatol Ges; 2017 Feb; 15(2):228-241. PubMed ID: 28036140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo administration of intravenous immunoglobulin (IVIg) can lead to enhanced erythrocyte sequestration.
    Kessary-Shoham H; Levy Y; Shoenfeld Y; Lorber M; Gershon H
    J Autoimmun; 1999 Aug; 13(1):129-35. PubMed ID: 10441177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [European Guidelines (S1) on the use of high-dose intravenous immunoglobulin in dermatology].
    Hadaschik E; Eming R; French LE; Girolomoni G; Hertl M; Jolles S; Karpati S; Steinbrink K; Stingl G; Volc-Platzer B; Zillikens D; Enk A
    Hautarzt; 2020 Jul; 71(7):542-552. PubMed ID: 32435817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin use in patients with toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Mittmann N; Chan B; Knowles S; Cosentino L; Shear N
    Am J Clin Dermatol; 2006; 7(6):359-68. PubMed ID: 17173470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.